N. Goardon

发表

Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.

P. Vyas, A. Mead, T. Enver, 2011, Cancer cell.

Ectopic expression of TAL-1 protein in Ly-6E.1-htal-1 transgenic mice induces defects in B- and T-lymphoid differentiation.

P. Romeo, H. Jouault, E. Dzierzak, 2002, Blood.

Heterogeneity of human lympho-myeloid progenitors at the single cell level

F. Hamey, B. Göttgens, A. Reinisch, 2017, Nature Immunology.

Heterogeneity of human lympho-myeloid progenitors at the single cell level

F. Hamey, A. Reinisch, P. Vyas, 2018 .

ETO2 coordinates cellular proliferation and differentiation during erythropoiesis

T. Hoang, Patrick Rodriguez, J. Strouboulis, 2006, The EMBO journal.

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol

J. Grellard, B. Clarisse, M. Lange, 2019, BMC Cancer.

NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia

J. Cayuela, A. Baruchel, P. Romeo, 2010, The Journal of experimental medicine.

Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia.

P. Vyas, M. Copland, R. Clark, 2016, Blood advances.

Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes

P. Vyas, M. Drayson, C. Craddock, 2009, Haematologica.

5 ' Azacitidine in Combination with Valproic Acid Induces Complete Remissions in Patients with Advanced Acute Myeloid Leukaemia but Does Not Eradicate Clonal Leukaemic Stem/Progenitor Cells.

P. Vyas, C. Craddock, S. Siddique, 2008 .

Quantitation of Leukemic Stem Cell Populations Predicts Clinical Outcome in Acute Myeloid Leukaemia

I. Weissman, P. Vyas, C. Craddock, 2011 .

murine megakaryopoiesis is critical for p21 SCL-mediated regulation of the cell-cycle regulator

P. Vyas, D. Ferguson, S. Watson, 2012 .

SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis.

P. Vyas, D. Ferguson, S. Watson, 2011, Blood.

TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma

J. Grellard, B. Clarisse, F. Joly, 2022, BMC Cancer.

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes

T. Frebourg, Baptiste Brault, P. Berthet, 2014, European Journal of Human Genetics.

Genetically distinct leukemic stem cells in human CD34− acute myeloid leukemia are arrested at a hemopoietic precursor-like stage

P. Vyas, A. Mead, C. Craddock, 2016, The Journal of experimental medicine.

Low SCL/TAL1 expression reveals its major role in adult hematopoietic myeloid progenitors and stem cells.

P. Romeo, F. Pflumio, N. Goardon, 2006, Blood.

Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families

T. Frebourg, Baptiste Brault, P. Berthet, 2018, Genetics in Medicine.

Detecting splicing patterns in genes involved in hereditary breast and ovarian cancer

C. Houdayer, T. Frebourg, Baptiste Brault, 2017, European Journal of Human Genetics.

Low SCL / TAL 1 expression reveals its major role in adult hematopoietic myeloid progenitors and stem cells

P. Romeo, F. Pflumio, N. Goardon, 2006 .

NKX 3 . 1 is a direct TAL 1 target gene that mediates proliferation of TAL 1-expressing human T cell acute lymphoblastic leukemia

J. Cayuela, A. Baruchel, P. Romeo, 2010 .

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia

I. Weissman, P. Vyas, C. Craddock, 2013, Leukemia.

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol

J. Grellard, B. Clarisse, M. Lange, 2019, BMC Cancer.

Assessment of branch point prediction tools to predict physiological branch points and their alteration by variants

A. Spurdle, N. Sevenet, C. Houdayer, 2019, BMC Genomics.

Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families

T. Frebourg, Baptiste Brault, P. Berthet, 2018, Genetics in Medicine.

Alternative splicing and ACMG-AMP-2015-based classification of PALB2 genetic variants: an ENIGMA report

Sitao Wu, A. Spurdle, M. Southey, 2019, Journal of Medical Genetics.

FLT3-ITDs Instruct a Myeloid Differentiation and Transformation Bias in Lymphomyeloid Multipotent Progenitors

I. Macaulay, P. Woll, P. Vyas, 2013, Cell reports.

ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies

L. weiswald, E. Babin, J. Thariat, 2023, BMC Cancer.

Correction: Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study

Patricia Marino, Rajae Touzani, Lionel Perrier, 2018, European Journal of Human Genetics.

Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study

Dede Sika Kossi, On behalf of NGSEco Group, I. Durand-zaleski, 2017, European Journal of Human Genetics.

Bivalent chromatin modification

P. Vyas, M. Gobbi, T. Enver, 2013 .

Generation of bivalent chromatin domains during cell fate decisions

P. Vyas, T. Enver, S. Jacobsen, 2011, Epigenetics & Chromatin.

Co-Existence of LMPP-Like and GMP-Like Leukemia Stem Cells In Acute Myeloid Leukemia

P. Woll, P. Vyas, A. Mead, 2010 .

Genetic profiles of cervical tumors by high-throughput sequencing for personalized medical care

A. Nicolas, X. Sastre, T. Frebourg, 2015, Cancer medicine.

Reduced CD38 Expression on CD34+Cells as a Diagnostic Test in Myelodysplastic Syndromes.

P. Vyas, C. Craddock, S. Freeman, 2008 .

A NOVEL MODEL OF HUMAN LYMPHO-MYELOID PROGENITOR HIERARCHY BASED ON SINGLE CELL FUNCTIONAL AND TRANSCRIPTIONAL ANALYSIS

F. Hamey, B. Göttgens, A. Reinisch, 2017 .

Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study

B. Clarisse, S. Bardet, L. Leenhardt, 2020, Endocrine.

Concordance between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial.

I. Soubeyran, I. Vergote, N. Sevenet, 2020, Journal of the National Cancer Institute.

Heterogeneity of human lympho-myeloid progenitors at the single cell level

F. Hamey, B. Göttgens, A. Reinisch, 2017, Nature Immunology.

Bivalent chromatin modification

P. Vyas, T. Enver, S. Luc, 2013 .

OutLyzer: software for extracting low-allele-frequency tumor mutations from sequencing background noise in clinical practice

Dominique Vaur, Sophie Krieger, Baptiste Brault, 2016, Oncotarget.

Correction: Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study

Dede Sika Kossi, On behalf of NGSEco Group, I. Durand-zaleski, 2018, European Journal of Human Genetics.

SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis.

P. Vyas, D. Ferguson, S. Watson, 2011, Blood.

Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study

Lionel Perrier, Isabelle Durand-Zaleski, Rajae Touzani, 2018, European Journal of Human Genetics.

2022-RA-935-ESGO Development of an academic genomic instability score for ovarian cancers

C. Genestie, I. Ray-Coquard, F. Coulet, 2022, Ovarian cancer.